Greg Mouchka

Greg Mouchka is President of iFyber, LLC, a specialty contract research organization focused on meeting the needs of medical device, pharmaceutical, biologics companies. Greg is responsible for providing strategic leadership to the organization and creating and implementing processes supporting the core mission of the company. He brings over 15 years of industry experience working with a range of companies, from medical device start-ups to mature established organizations. With a strong cross-functional background and understanding of the product development process, Greg has developed and executed the business and development plans of large multi-stakeholder projects for both medical device and applied market technologies. Greg continues to successfully expand the business through the development of successful corporate and government relationships and by building and maintaining a dynamic and innovative team. This includes acquisition of NovaSterilis, the global leader in supercritical carbon dioxide sterilization, decellurization, and tissue processing, in 2020.  Greg holds a B.S. and M.S. in mechanical engineering from Oregon State University.